Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Nurse Education Today|August 6, 2024
Uncovering the factors underlying collaboration outcomes in interprofessional education: A preliminary investigation involving healthcare studentsXiaoai Shen, John Ian Wilzon T Dizon, Yin Kei Doris Chong, et al.
The Journal of Infectious Diseases|February 13, 2024
Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB-Containing VaccinesSpyros Chalkias, Nichole McGhee, Jordan L Whatley, et al.
Acta Neuropathologica Communications|March 19, 2025
Spatiotemporal perturbations of the plasminogen activation system in a rat model of acute organophosphate intoxicationThomas J Blackmon, Jeremy A MacMahon, Pedro N Bernardino, et al.
BMC Medical Research Methodology|December 13, 2022
Methodology of the INVestigating traIning assoCiated blasT pAthology (INVICTA) studyMichael J Roy, David O Keyser, Sheilah S Rowe, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in miceBaoling Ying, Suzanne M Scheaffer, Bradley Whitener, et al.
Vaccine|November 24, 2021
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in miceKai Wu, Angela Choi, Matthew Koch, et al.
Biorxiv : the Preprint Server for Biology|October 20, 2022
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variantSuzanne M Scheaffer, Diana Lee, Bradley Whitener, et al.
Biorxiv : the Preprint Server for Biology|April 21, 2021
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in miceKai Wu, Angela Choi, Matthew Koch, et al.
Nature Medicine|October 20, 2022
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in miceSuzanne M Scheaffer, Diana Lee, Bradley Whitener, et al.
Science Translational Medicine|September 13, 2023
Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2Guillaume B E Stewart-Jones, Sayda M Elbashir, Kai Wu, et al.
Pageof 10